PRESS

In the News

Biotricity, News

Biotricity expands development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats

Biotricity Inc. (Biotricity) today announced the expanding development of its future Cardiac AI Cloud platform. The new platform is focused on predictive monitoring to help assist physicians and users to identify issues before they occur, supporting earlier interventions, reducing readmissions, and lowering healthcare costs. Biotricity’s product portfolio is already one of the most comprehensive remote cardiac monitoring portfolios globally. This expansion will further enhance its existing products while providing additional advantages.


Read More

Biotricity, Financial Results

Biotricity delivers record margins and double digit year-over-year sales growth for second quarter of fiscal year 2024

Biotricity Inc. (Biotricity) today announced its financial results for the second quarter of fiscal 2024 year and (unaudited) ended September 30, 2023.  Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, “In the second quarter of fiscal 2024, we continued our mission to innovate and create transformative healthcare products, all while maintaining a strong commitment to financial discipline. Our primary focus remains on driving revenue and margins and as such, we are pleased to see continued progress in achieving improvement in these metrics”.


Read More

Biotricity, Healthcare

Biotricity releases another groundbreaking product: Biotres Pro

Biotricity Inc. (Biotricity) today announced their expansion of the current Biotres product platform. The new product, known as Biotres Pro, adds cellular backup for offline connectivity in addition to the existing unique feature set. Biotres has been a game-changing product to the cardiac health market since its release. Biotres Pro continues this trend and establishes Biotricity’s product portfolio as the most comprehensive remote cardiac monitoring product portfolio globally.


Read More

Biotricity, Healthcare

Biotricity continues to expand patent portfolio with latest patent filing for Bioheart device

Biotricity Inc. (Biotricity) today announced its patent filing for the company’s Bioheart device. Bioheart, regarded as one of the most innovative wearable heart monitoring solutions and recognized as one of TIME Magazine’s Best Inventions of 2022 stands as a “game changer” in the industries of personal heart and remote lifestyle monitoring. This patent safeguards Bioheart’s exclusive 3-view dry-contact technology, advanced sensor system, unique design, and compact form factor, a combination that’s never been seen in the consumer market.


Read More

Biotricity, Healthcare

Biotricity announces patent filing for cutting-edge Biotres device

Biotricity Inc. (Biotricity) today announced the filing of a patent application for its groundbreaking Biotres device. This patent protects Biotres’ proprietary 3 channel technology, multiple sensors, architecture and compact form factor, a combination that has never been done before.  This filing expands the Company’s IP portfolio while increasing market barriers.


Read More

Biotricity, Healthcare

Biotricity unveils a new digital presence, highlighting its expanding technology portfolio and cutting-edge innovations

Biotricity Inc. (Biotricity)announced today the official launch a new digital presence that illustrates more completely the depth of Biotricity technologies and solutions.  The company has built a suite of solutions that combine connectivity, smart analytics, AI and cutting-edge cloud technologies. The solutions support individuals and patients from diagnostics to disease management depending on the solution utilized.


Read More

1 2 3 7 8
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from - Youtube
Vimeo
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Spotify
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound